Next Article in Journal
Enhancement of Forskolin Production Using Aeroponic Cultivation of Coleus forskohlii and the Impact on the Plant Phytochemistry
Previous Article in Journal
Is Passynski’s Approach to Hydration Numbers Consistent with Thermodynamics?
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 29
Issue 17
10.3390/molecules29174216
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Cytotoxic Activity and Metabolic Profiling of Hyptis rhomboidea Mart. et Gal

by
Jian Zhang
,
Wenjie Gao
,
Israt Jahan
,
Run Zhai
,
Kaiwei Yao
,
Jian Yan
* and
Ping Li
*
Key Laboratory of Agro-Environment in the Tropics, College of Natural Resources and Environment, South China Agricultural University, Guangzhou 510642, China
*
Authors to whom correspondence should be addressed.
Molecules 2024, 29(17), 4216; https://doi.org/10.3390/molecules29174216
Submission received: 12 August 2024 / Revised: 30 August 2024 / Accepted: 3 September 2024 / Published: 5 September 2024
(This article belongs to the Topic Antitumor Activity of Natural Products and Related Compounds—2nd Edition)
Browse Figures
Versions Notes

Abstract

:
Many naturally occurring chemical metabolites with significant cytotoxic activities have been isolated from medicinal plants and have become the leading hotspot of anti-cancer research in recent years. Hyptis rhomboidea Mart. et Gal is used as a folk medicine in South China to treat or assist in the treatment of liver disease, ulcers, and edema. But its chemical constituents have not been fully investigated yet. This study aimed to assess the cytotoxicity of H. rhomboidea, which was chemically characterized by chromatography–mass spectrometry methods. The results showed that the 95% ethanol extract of H. rhomboidea has marked inhibitory effects on five human cancer cell lines (HL-60, A549, SMMC-7721, MDA-MB-231, and SW480), with IC50 values ranging from 15.8 to 40.0 μg/mL. A total of 64 compounds were identified by ultra-high-performance liquid chromatography with quadrupole time-of-flight mass spectrometry (UPLC-QTOF-MS) and gas chromatograph–mass spectroscopy (GC-MS) analysis of H. rhomboidea crude extract. Among them, kaempferol, quercetin, rosmarinic acid, squalene, and campesterol were found to be abundant and might be the major metabolites involved to its bioactivity. The cytotoxic characterization and metabolite profiling of H. rhomboidea displayed in this research provides scientific evidence to support its use as medicinal properties.

1. Introduction

Cancer is one of the most dangerous diseases, posing a significant threat to human health worldwide. According to GLOBOCAN 2020 statistics on cancer incidence and mortality, there were approximately 19.3 million new cancer cases and nearly 10 million cancer deaths in 2020 [1]. Among them, breast cancer (2.3 million), lung cancer (2.24 million), colorectal cancer (1.97 million), prostate cancer (1.44 million), and stomach cancer (1.1 million) are still high-incidence diseases, with lung cancer causing the highest number of deaths annually. Despite substantial advancements in cancer biology, oncology, and surgical techniques in recent years, the overall survival rate for cancer has only slightly improved over the past decades, and this disease remains one of the leading causes of death [2,3,4]
Currently, the main treatment methods for cancer include radiotherapy, chemotherapy, and surgery [5]. While these treatments can be effective, the toxicity of anti-cancer drugs and the development of drug resistance in cancer cells often diminish their efficacy and result in significant side effects, such as nausea and loss of appetite [6,7,8]. Research has discovered that some natural plant compounds possess significant cytotoxicity against cancer cells lines, and they are abundantly available and have few toxicity side effects [9]. Therefore, natural plant compounds are important raw ingredients for exploring novel anti-cancer drugs. Combining natural anti-cancer compounds with conventional chemotherapy drugs can help to jointly inhibit cancer cell growth, prevent the development of drug resistance in tumor cells, and reduce the adverse side effects associated with chemotherapy [10]. A total of 185 small anticancer drugs were approved by the U.S. Food and Drug Administration (FDA) for their anticancer activity from 1946 to 2019. Among them, 75 small-molecule drugs (41% of the total) originated from natural products and their derivatives [11]. Therefore, natural products play significant role in new drug discovery and development.
Hyptis rhomboidea Mart. et Gal (Figure 1), also called H. decurrens, Pycnanthemum decurrens, is a medicinal plant belonging to the Lamiaceae family, native to tropical and subtropical regions of North America and widely distributed in the coastal areas of South China [12,13]. It is used as Chinese folk medicine to assist in the treatment of hepatitis, ulcers, and edema [14]. Phytochemical and pharmacological studies revealed that H. rhomboidea mainly contains phenylpropanoids, terpenoids, and phenolic acid. For example, hyprhombin C and epi-hyprhombin B (first identified in H. rhomboidea) demonstrate excellent anti-xanthine oxidase activity [15]. Caryophyllene oxide can be used to relieve pain without inducing psychoactive side effects, while ursolic acid is effective in treating autoimmune arthritis [16,17]. However, there are no reports about the cytotoxic activity of H. rhomboidea in human cancer cells.
In this study, the cytotoxic activities of H. rhomboidea ethanol extract against five human cancer cell lines including leukemia (HL-60), hepatoma (SMMC-7721), lung cancer (A-549), breast cancer (MDA-MB-231), and colon cancer (SW480) were assessed by the MTS method [18]. Based on the activity screening results, the metabolic profiling of H. rhomboidea extract was further analyzed using ultra-high-performance liquid chromatography coupled to quadrupole time-of-flight mass spectrometry (UPLC-QTOF-MS) and gas chromatography–mass spectrometry (GC-MS). This analysis helped to explore the potential cytotoxicity of natural products from the medicinal plant H. rhomboidea against human cancer cell lines.

2. Results

2.1. Cytotoxic Activity Evaluation of H. rhomboidea Crude Extracts

To investigate the cytotoxic activity of ethanol extracts from H. rhomboidea, five types of human cancer cells (HL-60, A549, SMMC-7721, MDA-MB-231, and SW480) were incubated with 100 µg/mL of the extracts. The cell viability of the cultured cancer cells was measured using MTS assays, evaluated the cytotoxicity of 95% and 50% ethanol extracts of H. rhomboidea against the five human cancer cell lines.
The 95% ethanol extract (HR-95) exhibited significant cytotoxic activity against the growth of the five types of cancer cells in vitro. Compared with normal human cells (BEAS-2B), HR-95 exhibited a significantly higher inhibitory effect against the five human tumor cell types (Figure 2). Notably, the extract was particularly effective in inhibiting the growth of leukemia (HL-60) and breast cancer (MDA-MB-231) cells, with rates of 96.10% and 90.54%, respectively. The inhibition rates against hepatoma (A549), lung cancer (SMMC-7721), and colon cancer (SW480) cell growth were 78.24%, 79.43%, and 85.64%, respectively. In contrast, the 50% ethanol extract (HR-50) had low inhibitory effect on cell viability and promoted HL-60 cell growth by 41.52%. For the negative control, both extracts exhibited no cytotoxic activity against the growth of human normal lung epithelial cells (BEAS-2B), with inhibition rates of only 14.20% and 1.57%, respectively (Table 1).

2.2. Screening of the 95% Ethanol Extract for Cytotoxic Activity against Human Cancer Cell Lines

After assessing the cytotoxic activity of H. rhomboidea (HR-95), it was observed that HR-95 exhibits obviously inhibitory activity, with half-maximal effectiveness against the growth of the five human cancer cell lines in vitro. Therefore, the cell viability of cancer cells was determined using the MTS method at different concentrations of HR-95 (0, 0.8, 4, 20, 100 μg/mL). Positive control compounds included different concentrations of cisplatin and Taxol.
After 48 h of incubation, cell viability assays were performed to evaluate the cytotoxic effects of HR-95 on the five human cancer cell lines. HR-95 and the positive control cisplatin exhibited poor inhibitory effects on the proliferation of human normal lung epithelial cells (BEAS-2B), and HR-95 possessed satisfactory cytotoxic activity against the five human cancer cell lines compared with the positive control cisplatin, with particularly noteworthy inhibitory effects on breast cancer (MDA-MB-231) and colon cancer cells (SW480) (Figure 3). Based on IC50 calculations, HR-95 exhibited distinct half-maximal inhibitory concentrations against the following five cancer cell lines: HL-60 (36.44 ± 1.82 μg/mL), A549 (40.02 ± 0.58 μg/mL), SMMC-7721 (26.20 ± 0.77 μg/mL), MDA-MB-231 (22.95 ± 1.59 μg/mL), and SW480 (15.81 ± 0.63 μg/mL) (Table 2). The results indicate that HR-95 contains compounds with potential cytotoxic activity against human cancer cell lines and warrants further isolation and identification for characterization.

2.3. Metabolic Profiling of H. rhomboidea

The results of the MTS assay showed that the 95% ethanol extract of the whole H. rhomboidea (HR-95) plant had great cytotoxic activity, while 50% extract had no inhibitory activity. To elucidate the chemical constituents (HR-95) with cytotoxic activity, LC-MS and GC-MS analysis were performed to characterize the metabolite profiles.

2.3.1. Non-Volatile Chemical Compound Analysis

To identify the non-volatile compositions of HR-95, UPLC-QTOF-MS conditions were optimized to establish the suitable elution gradient, ratio of formic acid in the mobile phase, operating voltage, and other parameters and achieve optimal chromatographic peak intension and separation. The identification of metabolites was performed by combining the positive and negative ion modes to obtain base peak chromatograms. The results were retained at the initial 10 min, and chromatographic peaks found in blank samples were excluded to enhance the accuracy of the analysis (Figure 4). Different types of metabolites were detected between positive and negative ion modes, with the total peak intensity notably higher in positive ion mode than in negative ion mode.
Based on the retention time, high-resolution mass spectra molecular ions and the fragment ions of peaks were obtained from the low-energy and ramp collision energy of MSE data. According to the rules of ion fragmentation, compared with open-source mass spectral libraries and the literature on the Hyptis genus, 25 compounds with relatively high contents including eleven flavonoids, six terpenoids, two coumarins, three aliphatic derivatives, two aromatic derivatives, and one saccharide were tentatively identified from HR-95 (Table 3).
Among the identified compounds, three types of flavonoids were categorized as follows: flavonols, flavones, and flavanes. These flavonoids exhibited strong molecular or quasi-molecular ion peaks using the ESI ion source. Peaks 4, 6, and 14 exhibited molecular ions [M + H]+ at m/z 303.0482, 287.0534, and 329.1004, respectively. The protonated molecular ion of the peak 4 m/z produced 285.0365 [M + H − 18], 257.0420 [M + H − 46], and 229.0467 [M + H − 74] ion fragments, identified as quercetin, and the inferred process for the cleavage is shown in Figure 5 [19]. Peak 6 generated ion fragments at m/z 213.0517 [M + H − 74], 153.0153 [M + H − 134], and 121.0255 [M + H − 166], identified as kaempferol [20]. While peak 14 produced ion fragments at m/z 314.0764 [M + H − 15], 296.0660 [M + H − 33], and 268.0708 [M + H − 61], identified as 3′,4′,5′-trimethoxyflavonol [21]. All of three compounds belong to flavonols.
Peaks 2 and 3 presented the molecular ions [M + H]+ at m/z 611.1622 and 465.1021, respectively. Nonetheless, they shared the same daughter ions of m/z 303.0482 (quercetin glycoside fragment), 229.0467, and 153.0151. Thus, peaks 2 and 3 were identified as rutin and spiraeoside [22,23]. Peaks 5 and 7 were detected in negative ion mode and exhibited the molecular ion [M − H]− at m/z 593.1633 and 447.0931, respectively. Moreover, peak 5 produced fragment ions at m/z 285.0405 [M − H − 308], 255.0302 [M − H − 338], and 227.0351 [M − H − 366], which was identified as nicotiflorin [24]. Peak 7 possessed fragment ions at m/z 285.0325 [M − H − 163], 255.0296 [M − H − 192], and 227.0345 [M − H − 220], which was identified as astragalin [25]. These four compounds were classified as flavonol glycosides.
Peak 12 was observed the molecular ion [M − H]− at m/z 283.0611, and the deprotonated molecule yielded several characteristic ion fragments at m/z 268.0373 [M − H − 15], 240.0415 [M − H − 43]; and 211.0393 [M − H − 72]; thus, it was speculated to be genkwanin [26]. Peak 16 was deduced as 5-Hydroxy-4′,7-dimethoxyflavone based on its molecular ion [M + H]+ at m/z 299.0893 and fragment ions at m/z 284.0655 [M + H − 15] and 256.0708 [M + H − 43] [27]. These two compounds were classified as flavones. Peak 9 and 11 belonged to flavanes, where peak 9 had a precursor ion [M + H]+ of m/z 423.1254 and a product ion [M + H − 60] of m/z 363.1036, compared with the pubchem database, and was tentatively identified as catechin 7-arabinofuranoside. Peak 11 produced a molecular ion [M − H]− of m/z 453.0722 and fragment ions of m/z 329.2333 [M − H − 124] and 160.8415 [M − H − 293], which was inferred to be theaflavic acid based on the literature and databases [25].
Peaks 8 and 23 belonged to coumarins, and the molecular ions [M − H]− were identified as rosmarinic acid and rutamarin at m/z 359.0769 and 355.1586, respectively. The possible identifications of the other 12 peaks are summarized in Table 3 and not described here.
Table 3. The chemical constituents in HR-95 tentatively identified by UPLC-QTOF-MS.
Table 3. The chemical constituents in HR-95 tentatively identified by UPLC-QTOF-MS.
Peak
No.		RT (min)Molecular
Weight (Da)		Putative CompoundClassMolecular
Formula		Fragment Ions
m/z		Reference
10.488378GeshoidinSaccharidesC18H18O9377.0846/313.0864/173.8846/161.8413/160.8414[28]
23.071610RutinFlavonoidsC27H30O16519.0209/340.9951/303.0482/229.0467/153.0153[22]
33.072464SpiraeosideFlavonoidsC21H20O12465.1013/303.0482/229.0467/153.0151/137.0202[23]
43.141302QuercetinFlavonoidsC15H10O7303.0482/285.0369/257.0420/229.0467/153.0153[19]
53.220594NicotiflorinFlavonoidsC27H30O15593.1539/285.0405/255.0302/227.0351[24]
63.221286KaempferolFlavonoidsC15H10O6287.0539/213.0517/165.0154/153.0153/121.0255[20]
73.289448AstragalinFlavonoidsC21H20O11447.0931/284.0325/255.0296/227.0345[25]
83.454360Rosmarinic acidCoumarinsC18H16O8359.0773/197.0451/179.0346/161.0242/133.0290/134.0450[29]
93.752422Catechin 7-arabinofuranosideFlavonoidsC20H22O10423.1254/363.1036-
104.083382ResorcinolnaphthaleinAromatic derivativesC24H14O5383.0852/347.1084/333.1290/287.0863/205.0828-
114.547428Theaflavic acidFlavonoidsC21H16O10453.0722/329.2333/160.8415[25]
125.193284GenkwaninFlavonoidsC16H12O5283.0607/268.0373/240.0415/211.0393/161.0239/151.0023[26]
135.673488Uncaric acidTerpenoidsC30H48O5487.3456/469.3322/425.3420-
145.7933123′,4′,5′-TrimethoxyflavonolFlavonoidsC18H16O6329.1001/314.0764/296.0660/268.0708[21]
156.204488Asiatic acidTerpenoidsC30H48O5533.3480/487.3429[30]
166.2732985-Hydroxy-4′,7-dimethoxyflavoneFlavonoidsC17H14O5299.0893/284.0655/256.0708/184.0704[31]
176.372949-HOTrEAliphatic derivativesC18H30O3293.2122/275.9977/231.1745/171.9812[32]
186.684472Maslinic acidTerpenoidsC30H48O4472.3516/471.3482/405.3159[33]
196.788296α-Dimorphecolic acidAliphatic derivativesC18H32O3295.2278/277.2173/171.3940[34]
206.902472Corosolic acidTerpenoidsC30H48O4472.3513/471.3484[35]
218.159456Ursolic acidTerpenoidsC30H48O3455.3534/407.3311[36]
228.6283344-Ethenyloctahydro-2-hydroxy-4,5′,8′a-trimethyl-1′-oxospiro[cyclopentane-1,2′(1′H)-naphthalene]-5′-carboxylic acidTerpenoidsC20H30O4333.2288/235.8418/137.8908-
239.091356RutamarinCoumarinsC21H24O5355.1585/119.9463[37]
249.68159812b-O-[deca-2Z,4E-dienoyl]-13a-isobutyl-5-ene-7-oxo-4b-phorbolAromatic derivativesC34H46O9621.3096/533.2560/434.2414-
259.7723902-acetoxy-4-pentadecylbenzoic acidAliphatic derivativesC24H38O4413.2644/301.1388-
Peak No. is the same in Figure 3; RT indicates retention time.

2.3.2. Volatile Compound Analysis

For the comprehensive identification of volatile components, GC-MS was performed using an optimized temperature program and split ratio. The total ion chromatogram result is shown in Figure 5. Based on the retention index and mass spectra information, compounds were identified by comparing them to the NIST 2020 library database. As a result, 39 volatile compounds were assigned to terpenoids, phytosterols, aromatic derivatives, and aliphatic derivatives, accounting for 25.00% of the total content (Figure 6a). Moreover, terpenoids had the highest content, comprising 12.21%, including monoterpeneoids (1.0%), sesquiterpenoids (5.19%), diterpenoids (1.75%), and triterpenoids (4.27%). Among them, the compounds with the highest contents were estragole, γ-muurolene, phytol, and squalene (Figure 6b). Aromatic and aliphatic derivatives, such as 2,4-di-tert-butylphenol and 2-hexadecen-1-ol, 3,7,11,15-tetramethyl-acetate (a diterpenoid derivative), accounted for 1.56% and 1.50% of the total content, respectively. The phytosterols includes campesterol and stigmasterol, with 1.00% and 2.85% of the total content, respectively (Table 4).

3. Discussion

H. rhomboidea, a traditional herbal medicine used to treat hepatitis, has been investigated for its chemical constituents, antimicrobial activity, and cytotoxicity activity against the murine tumor cell line in few studies [14,38]. We evaluated the cytotoxic activity of H. rhomboidea ethanol extract on five human cancer cell lines for the first time. The results indicated that the 95% ethanol extract of H. rhomboidea (HR-95) exhibits pronounced inhibitory activity, while the 50% extract (HR-50) shows no significant effect. However, HR-50 significantly inhibits NO production in murine monocyte–macrophages, indicating its excellent anti-inflammatory effects. At a concentration of 50 μg/mL, HR-50 achieved an inhibition rate of 97.23% on NO production. Nevertheless, it also exhibited cytotoxicity (Table S1). In addition, both of the extracts (HR-95 and HR-50) showed no cytotoxic against non-cancer cells (normal human lung epithelial cells), which demonstrated that the H. rhomboidea extracts have selectivity against human cancer cells. This finding indicates that the potential cytotoxicity of the ethanol extract from H. rhomboidea are relative to the polarity of its metabolites, and the big polar compounds from the 50% ethanol extract may associate with their anti-inflammatory activity. These results support the medicinal value of H. rhomboidea.
The MTS assay revealed that the 95% ethanol extract of H. rhomboidea exhibited lower cytotoxic activity against the five human cancer cell lines compared with the positive controls (cisplatin and Taxol), yet it still demonstrated a moderate level (the extract showed over half inhibitory rate at 100 µg/mL) of an inhibitory effect, with IC50 values ranging from 15.8 μg/mL to 40.0 μg/mL. This may be attributed to the low concentration of the bioactive metabolites and the interaction of multiple compounds. The separation and purification of bioactive compounds can enhance their cytotoxicity against cancer cells. Consequently, the chemical composition of HR-95 was investigated using LC-MS and GC-MS.
In this study, we employed LC-MS and GC-MS methods to analyze and characterize the chemical composition of HR-95, resulting in the identification of various potential biologically active compounds. Among them, flavonoids were the main components in H. rhomboidea crude extract. Previous studies have reported that flavonoids possess extensively cytotoxicity against cancer cells [39,40]. Studies have found that 3′,4′,5′-trimethoxyflavonol induces apoptosis in TRAMP C2 prostate cancer cells [41]. Quercetin not only triggers apoptosis in human colon cancer cells by inhibiting the nuclear factor-kappa B pathway but also suppresses proliferation and invasion in breast cancer cells through the up-regulation of miR-146a. It further induces autophagy-associated cell death in HL-60 cells via the CaMKKβ/AMPK/mTOR signaling pathway and exhibits other anti-tumor effects as well [42,43,44,45]. Kaempferol induces the cell cycle at the G2/M phase in MDA-MB-453 breast cancer cells and reverses the EMT process in gastric, ovarian, and breast cancer cells by modulating key markers such as E-cadherin, Smad2/4, TGF-β, N-cadherin, vimentin, and Snai1 [46,47]. Astragalin has been shown to effectively inhibit the proliferation of leukemia (HL-60), hepatocellular (HepG2), skin (HaCaT), and lung (A549) cancer cells [48]. Meanwhile, genkwanin demonstrates strong efficacy in inhibiting the proliferation and metastasis of A549 and H69AR cancer cells and shows potential in treating colon cancer and B16F10 melanoma [49]. The effective inhibition of human tumor cells by the H. rhomboidea extract may be attributed to these compounds.
Furthermore, rosmarinic acid, corosolic acid, rutin, spiraeoside, rutamarin, and some other compounds also demonstrated definite inhibitory activity on tumor cells [50,51,52,53,54]. Terpenoids were the main components of volatile compounds, and squalene (triterpenoids) exhibited notable cytotoxic effect on cancer cells [55]. Additionally, phytosterols, i.e., campesterol and stigmasterol, also possessed cytotoxic activity against human cancer cells [56,57]. These compounds may inhibit the synthesis of proteins and the replication of DNA in cancer cells to promote the cytotoxic activity of HR-95 against human cancer cell lines [58].
Previous studies have found that the main components of H. rhomboidea are phenolic acids and glycosides, which have inhibitory effects on plant pathogens such as Fusarium graminearum and Exserohilum turcicum [38]. The ethanol extract can improve the levels of serum TNF-α and IL-2 in mice, boost SOD activity, and decrease MDA content; thus, it can against the growth of digestive tumor cells with an inhibition activity of 68.84% [14]. However, there are few reports on the chemical composition of H. rhomboidea and their cytotoxicity against human cancer cells. In this study, we observed satisfactory activity of the ethanol extract of H. rhomboidea on human cancer cells for the first time. Subsequently, using metabolomics approaches with UPLC-QTOF-MS and GC-MS, we analyzed the chemical composition of the extract and identified potential active compounds associated with cytotoxicity, providing new insights into the isolation and purification of bioactive compounds. Moreover, merging bioactivity with metabolomic techniques can provide an effective strategy to discover bioactive compounds from medicinal plants [18], thereby addressing the limitations of traditional methods in isolating bioactive compounds.

4. Materials and Methods

4.1. Plant Materials

The H. rhomboidea plant was collected from Ledong county, Hainan province, China. Voucher specimens were verified by Dr. Haijun Yang (South China Agricultural University) and stored at −40 °C in the laboratory of chemical ecology until extraction.

4.2. Perparation of Crude Extract

The aerial part of H. rhomboidea was naturally air-dried and ground into a powder. The dried powder was weighed to 200 g accurately and evenly divided into 2 portions (100 g each). Subsequently, samples are extracted with 50% ethanol and 95% ethanol for 48 h and then sonicated at 20 °C for 30 min. Each sample underwent two extractions using the same method. The filtrate was concentrated with a vacuum rotary evaporator to produce dry residues. The 50% ethanol crude extract was 328 mg, and the 95% ethanol crude extract was 169 mg. The extracts were stored at −20 °C until use.

4.3. Cytotoxic Activity Assay

Human cancer cell lines HL-60 (leukemia), MDA-MB-231 (breast cancer), A-549 (lung cancer), and SW480 (colon cancer) were obtained from ATCC (Manassas, VA, USA), and SMMC-7721 (hepatoma) and BEAS-2B (normal human lung epithelial cells) were sourced from BeNa Culture Collection (BNCC, Beijing, China). The cells were cultured in either RMPI-1640 or DMEM medium (Biological Industries, Kibbutz Beit-Haemek, Israel) supplemented with 10% fetal bovine serum for a duration of 12 to 24 h [59]. The cytotoxic activity of the cancer cells was assessed using the MTS assay [60]. In short, the cells were diluted with medium to obtain a single-cell suspension and then inoculated to a 96-well plate. The crude extract (100 µg/mL, prepared in DMSO), the solvent DMSO (blank controls), 12.00 µg/mL (40 µM) cisplatin, and 4.27 µg/mL (5 µM) Taxol (positive controls) were added to 100 µL of the medium, resulting in a final volume of 200 μL and an initial concentration of 1 × 105 cells/mL. After incubating for 48 h at 37 °C, 100 μL of the culture medium was discarded and supplemented with 20 μL of the MTS solution. Each treatment was performed in triplicate. The treatments showing over 50% growth inhibition were further evaluated at different concentrations of the crude extracts, cisplatin, and Taxol. Specifically, the crude extract concentrations were 100 µg/mL, 20 µg/mL, 4 µg/mL, and 0.8 µg/mL. Furthermore, the cisplatin concentrations were 12.00 µg/mL (40 µM), 2.40 µg/mL (8 µM), 0.48 µg/mL (1.6 µM), 0.096 µg/mL (0.32 µM), and 0.019 µg/mL (0.064 µM), while the Taxol concentrations were 4.27 µg/mL (5 µM), 0.85 µg/mL (1 µM), 0.17 µg/mL (0.2 µM), 0.034 µg/mL (0.04 µM), and 0.0068 µg/mL (0.008 µM). Each treatment was tested in triplicate. After 48 h of cell incubation by the aforementioned protocol, the treatments were further incubated for an additional 4 h to ensure sufficient reaction time. Following incubation, cell viability was assessed by measuring the absorbance of the treatments at a wavelength of 492 nm using a Multiskan FC Microplate Photometer (Thermo Fisher Scientific, Waltham, MA, USA). The IC50 value of each treatment was determined with Reed and Muench’s method, followed by analysis and drawing using Origin 2022.

4.4. UPLC-QTOF-MS Analysis of Non-Volatile Compounds

The 95% ethanol crude extract of H. rhomboidea was dissolved in methanol to a final concentration of 1 mg/mL and filtered through a 0.22 μm PTFE filter for analysis [61]. The prepared samples were analyzed using an ACQUITY UPLC system connected to a Xevo G2-XS QTOF spectrometer (Waters Milford, Milford, MA, USA). Separation was achieved on an ACQUITY UPLC® BEH C18 column (2.1 mm × 50 mm, 1.7 µm; Waters) maintained at 40 °C, with an injection amount of 2 μL. The elution utilized a two-solvent system as follows: solvent A was water with 0.1% formic acid, and solvent B was acetonitrile with 0.1% formic acid. The gradient program was as follows: 0–1.0 min, 10% B; 1.0–2.0 min, 10~30% B; 2.0–8.0 min, 30–98% B; 8.0–10.0 min, 98% B; 10.0–10.2 min, 98~10% B; 10.2–13.0 min, and 10% B. The flow rate was set to 0.3 mL/min, and the autosampler temperature was maintained at 16 °C. High-resolution mass spectrometry was detected in both negative and positive ion sensitivity mode with an electrospray ionization source. The essential parameters of the Xevo G2-XS QTOF-MS included a capillary voltage of +2.50 kV and −1.5 kV, source temperature of 120 °C, desolvation temperature of 350 °C, cone gas flow rate of 50 L/h, desolvation gas flow rate of 800 L/h, scan time of 0.5 s, mass range of 100–1000 m/z, low energy of 5 V, and collision energy of 20~50 V. All compounds were detected using MSE mode to obtain fragmentation data in a single analysis.

4.5. GC-MS Analysis of Volatile Compounds

The 95% ethanol crude extract of H. rhomboidea was dissolved with methanol (with 5 mg/L ethyl caprate) to a concentration of 1 mg/L. Subsequently, the extracts were sonicated for 30 min in a 15 °C water bath, followed by drying over anhydrous sodium sulfate and stored at −4 °C for 12 h. Then, 1 mL of extraction solution was aspirated and filtered through a 0.22 μm PTFE into a 2 mL sample vial for GC-MS analysis.
The GC-MS analysis was conducted using a SHIMADZU TQ8040 GC-MS instrument, which featured a triple quadrupole configuration and a DB-5MS column (30 m × 0.25 mm × 0.25 μm, Agilent Technologies, Santa Clara, CA, USA). The GC parameters were as follows: helium was used as the carrier gas at a flow rate of 1 mL/min, the injection temperature was set to 230 °C, the detector temperature was 250 °C, the sample volume was 1 µL, and the split ratio was 3: 1. The oven temperature was increased using the following procedure: starting at 60 °C for 2min, ramped at 6 °C/min to 250 °C and kept for 15 min, then maintained 250 °C for 10 min. The MS utilized an EI ionization source operating at 70 eV, with a scan range of 50–500 m/z. The ion source temperature was set at 200 °C, and the GC-MS interface temperature was maintained at 250 °C. The raw compound data files were converted from QGD format to CDF format using SHIMADZU GSMSsolution (Ver. 4.52) for subsequent analysis.

4.6. Data Analysis

The raw data acquired from UPLC-QTOF-MS and GC-MS analyses were initially converted to ABF format files by ABF converter (Ver. 1.3). Subsequently, compound relative content, mass spectra information, relative retention index (RI), and relative retention time (RT) were obtained using MSDAIL (Ver. 4.9) for compound identification. The MSDAIL parameters were set to default. The non-volatile compounds of UPLC-MS were identified using the Massbank library, MSDAL standard compound library, METVARE self-built library, and published mass spectra. Meanwhile, the volatile compounds of GS-MS were identified using the NIST 2020 mass spectral library and published mass spectra, and the compounds with matching ≥ 800 were retained.

5. Conclusions

In this study, we first discovered that the 95% ethanol extract of H. rhomboidea exhibited moderate cytotoxic activities against five human cancer cell lines (HL-60, A549, SMMC7721, MDA-MB-231, and SW480), with IC50 values ranging from 15.8 to 40.0 μg/mL. Based on metabolomic analysis using UPLC-QTOF-MS and GC-MS methods, a total of 25 non-volatile and 39 volatile compounds from the active crude extract were identified, and several compounds had the potential cytotoxicity need further isolation and verification. These findings highlight the cytotoxic potential of H. rhomboidea and provide valuable insights for its further exploration and application in cancer research and therapeutic development.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/molecules29174216/s1: Table S1. The inhibitory rate of nitric oxide (NO) generation for two H. rhomboidea ethanol extracts and the positive control.

Author Contributions

W.G., J.Z. and R.Z. prepared the crude extracts and conducted the chemical analysis of the samples; W.G. and J.Z. performed the HPLC-QTOF-MS/MS analysis; R.Z. and J.Z. carried out the GC-MS analysis; J.Z., W.G. and K.Y. conducted partial cytotoxicity and anti-inflammatory cell experiments, with technical assistance provided by the Kunming Institute of Botany; J.Z., W.G. and P.L. analyzed the results; J.Z. wrote this manuscript; I.J., P.L. and J.Y. proofread this manuscript; J.Y. and P.L. were responsible for project management. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Natural Science Foundation of China (31800283, 32270417) and the Science and Technology Project of Nujiang Prefecture, Yunnan Province, China (202202AE090035).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are contained within the article and Supplementary Materials.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021, 71, 209–249. [Google Scholar] [CrossRef]
  2. Han, B.; Zheng, R.; Zeng, H.; Wang, S.; Sun, K.; Chen, R.; Li, L.; Wei, W.; He, J. Cancer incidence and mortality in China, 2022. J Natl. Cancer Cent. 2024, 4, 47–53. [Google Scholar] [CrossRef] [PubMed]
  3. Cronin, K.A.; Scott, S.; Firth, A.U.; Sung, H.; Henley, S.J.; Sherman, R.L.; Siegel, R.L.; Anderson, R.N.; Kohler, B.A.; Benard, V.B.; et al. Annual report to the nation on the status of cancer, Part 1: National cancer statistics. Cancer 2022, 128, 4251–4284. [Google Scholar] [CrossRef] [PubMed]
  4. Abu-Khudir, R.; Ismail, G.A.; Diab, T. Antimicrobial, antioxidant, and anti-tumor activities of sargassum linearifolium and cystoseira crinita from egyptian mediterranean coast. Nutr. Cancer 2021, 73, 829–844. [Google Scholar] [CrossRef]
  5. He, S.M.; Xu, J.; Liu, X.J.; Zhen, Y.S. Advances and challenges in the treatment of esophageal cancer. Acta Pharm. Sin. B 2021, 11, 3379–3392. [Google Scholar] [CrossRef]
  6. Song, G.; Cheng, L.; Chao, Y.; Yang, K.; Liu, Z. Emerging nanotechnology and advanced materials for cancer radiation therapy. Adv. Mater. 2017, 29, 1700996. [Google Scholar] [CrossRef] [PubMed]
  7. Banc, R.; Rusu, M.E.; Filip, L.; Popa, D.-S. Phytochemical profiling and biological activities of Quercus sp. galls (oak galls): A systematic review of studies published in the last 5 years. Plants 2023, 12, 3873. [Google Scholar] [CrossRef]
  8. Haif, S.K.; Al Kury, L.T.; Talib, W.H. Combination of thymoquinone and intermittent fasting as a treatment for breast cancer implanted in mice. Plants 2024, 13, 35. [Google Scholar] [CrossRef]
  9. Sharifi-Rad, J.; Ozleyen, A.; Tumer, T.B.; Adetunji, C.O.; El Omari, N.; Balahbib, A.; Taheri, Y.; Bouyahya, A.; Martorell, M.; Martins, N.; et al. Natural products and synthetic analogs as a source of antitumor drugs. Biomolecules 2019, 9, 679. [Google Scholar] [CrossRef]
  10. Zhou, H.; Zhang, M.; Cao, H.; Du, X.; Zhang, X.; Wang, J.; Bi, X. Research progress on the synergistic anti-tumor effect of natural anti-tumor components of Chinese herbal medicine combined with chemotherapy drugs. Pharmaceuticals 2023, 16, 1734. [Google Scholar] [CrossRef]
  11. Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J. Nat. Prod. 2020, 83, 770–803. [Google Scholar] [CrossRef] [PubMed]
  12. Li, X.F.; Tang, L.; Zheng, N.N.; An, S.; Wang, Y.X.; Zhang, W.X.; Hu, Y.N. Determination of antioxidant activity in vitro from Hyptis rhomboidea Mart. et Gal. ethanol extracts. Appl. Mech. Mater. 2014, 472, 824–828. [Google Scholar] [CrossRef]
  13. Wu, Z.Y.; Peter, R.; Hong, D.Y.; Aedo, C.; Cai, J.; Aiken, S.; Chang, C.S.; Akiyama, S.; Alexander, C.; Zhang, M.Z.; et al. Flora of China; Science Press: Beijing, China, 1994; Volume 17, p. 267. [Google Scholar]
  14. Cheng, F.-R.; Cui, H.-X.; Tang, L.; Yuan, K. Antitumor effects of ethanol extracts from Hyptis rhomboidea in H22 tumor-bearing mice. Pharmacogn. Mag. 2017, 13, 571–575. [Google Scholar] [CrossRef] [PubMed]
  15. Tsai, S.F.; Lee, S.S. Neolignans as xanthine oxidase onhibitors from Hyptis rhomboidea. Phytochemistry 2014, 101, 121–127. [Google Scholar] [CrossRef] [PubMed]
  16. Gyrdymova, Y.V.; Rubtsova, S.A. Caryophyllene and caryophyllene oxide: A variety of chemical transformations and biological activities. Chem. Pap. 2022, 76, 1–39. [Google Scholar] [CrossRef]
  17. Kadasah, S.F.; Radwan, M.O. Overview of ursolic acid potential for the treatment of metabolic disorders, autoimmune diseases, and cancers via nuclear receptor pathways. Biomedicines 2023, 11, 2845. [Google Scholar] [CrossRef]
  18. Quan, F.; Luan, X.; Zhang, J.; Gao, W.; Yan, J.; Li, P. Cytotoxic isopentenyl phloroglucinol compounds from Garcinia xanthochymus using LC-MS-based metabolomics. Metabolites 2023, 13, 258. [Google Scholar] [CrossRef]
  19. Li, Y.; Dai, H.; Wang, M.; Li, X.; Wang, L.; Xue, M. Elucidation of Quercetin by Electron Spray Ionization Mass Spectrometry. J. Chin. Mass. Spectrom. Soc. 2009, 30, 374–378. [Google Scholar]
  20. Jan, R.; Asaf, S.; Paudel, S.; Lubna; Lee, S.; Kim, K.M. Discovery and validation of a novel step catalyzed by OsF3H in the flavonoid biosynthesis pathway. Biology 2021, 10, 32. [Google Scholar] [CrossRef]
  21. Du, Z.Y.; Ng, H.F.; Zhang, K.; Zeng, H.Q.; Wang, J. Ionic liquid mediated cu-catalyzed cascade michael-oxidation: Efficient synthesis of flavones under mild reaction conditions. Org. Biomol. Chem. 2011, 9, 6930–6933. [Google Scholar] [CrossRef]
  22. He, J.; Feng, Y.; Ouyang, H.-z.; Yu, B.; Chang, Y.-x.; Pan, G.-x.; Dong, G.-y.; Wang, T.; Gao, X.-m. A sensitive LC–MS/MS method for simultaneous determination of six flavonoids in rat plasma: Application to a pharmacokinetic study of total flavonoids from mulberry leaves. J. Pharm. Biomed. Anal. 2013, 84, 189–195. [Google Scholar] [CrossRef]
  23. Cai, X.; Dai, X.; Li, Z.; Chen, J.; Wang, X.; Zhang, M. An UPLC-MS/MS method for quantification of spiraeoside in mouse blood and its application to a pharmacokinetic and bioavailability study. Acta Chromatogr. 2022, 35, 272–277. [Google Scholar] [CrossRef]
  24. Jang, G.H.; Kim, H.W.; Lee, M.K.; Jeong, S.Y.; Bak, A.R.; Lee, D.J.; Kim, J.B. Characterization and quantification of flavonoid glycosides in the Prunus genus by UPLC-DAD-QTOF/MS. Saudi J. Biol. Sci. 2018, 25, 1622–1631. [Google Scholar] [CrossRef] [PubMed]
  25. Li, M.; Zhang, Y.; Chen, C.; Zhong, S.; Li, M.; Xu, K.; Zhu, Y.; Li, P.; You, S.; Jin, S. Chemical and quality analysis of beauty tea processed from fresh leaves of tieguanyin variety with different puncturing degrees. Foods 2023, 12, 1737. [Google Scholar] [CrossRef] [PubMed]
  26. Yuan, L.; Liang, C.; Diao, X.; Cheng, X.; Liao, M.; Zhang, L. Metabolism studies on hydroxygenkwanin and genkwanin in human liver microsomes by UHPLC-Q-TOF-MS. Xenobiotica 2018, 48, 332–341. [Google Scholar] [CrossRef]
  27. McOtshana, Z.K.S.; McGaw, L.J.; Kemboi, D.; Fouche, G.; Famuyide, I.M.; Krause, R.W.M.; Siwe-Noundou, X.; Tembu, V.J. Cytotoxicity and antimicrobial activity of isolated compounds from Monsonia angustifolia and Dodonaea angustifolia. J. Ethnopharmacol. 2023, 301, 115170. [Google Scholar] [CrossRef] [PubMed]
  28. Chen, G.-L.; Munyao Mutie, F.; Xu, Y.-B.; Saleri, F.D.; Hu, G.-W.; Guo, M.-Q. Antioxidant, anti-inflammatory activities and polyphenol profile of Rhamnus prinoides. Pharmaceuticals 2020, 13, 55. [Google Scholar] [CrossRef]
  29. Wang, X.; Qian, Y.; Li, X.; Jia, X.; Yan, Z.; Han, M.; Qiao, M.; Ma, X.; Chu, Y.; Zhou, S.; et al. Rapid determination of rosmarinic acid and its two bioactive metabolites in the plasma of rats by LC-MS/MS and application to a pharmacokinetics study. Biomed. Chromatogr. 2021, 35, e4984. [Google Scholar] [CrossRef]
  30. Paemanee, A.; Rattanabunyong, S.; Ketngamkum, Y.; Siriwaseree, J.; Pongpamorn, P.; Romyanon, K.; Tangphatsornruang, S.; Kuaprasert, B.; Choowongkomon, K. Mass spectrometry and synchrotron-ftir microspectroscopy reveal the anti-inflammatory activity of bua bok extracts. Phytochem. Anal. 2022, 33, 1086–1098. [Google Scholar] [CrossRef]
  31. Kim, J.Y.; Park, K.-S.; Lee, C.; Chang, Y.-H. Synthesis of a complete series of o-methyl analogues of naringenin and apigenin. Bull. Korean Chem. Soc. 2007, 28, 2527–2530. [Google Scholar]
  32. Prost, I.; Dhondt, S.; Rothe, G.; Vicente, J.; Rodriguez, M.J.; Kift, N.; Carbonne, F.; Griffiths, G.; Esquerré-Tugayé, M.T.; Rosahl, S.; et al. Evaluation of the antimicrobial activities of plant oxylipins supports their involvement in defense against pathogens. Plant Physiol. 2005, 139, 1902–1913. [Google Scholar] [CrossRef]
  33. Peragón, J.; Rufino-Palomares, E.E.; Muñoz-Espada, I.; Reyes-Zurita, F.J.; Lupiáñez, J.A. A new HPLC-MS method for measuring maslinic acid and oleanolic acid in HT29 and HepG2 human cancer cells. Int. J. Mol. Sci. 2015, 16, 21681–21694. [Google Scholar] [CrossRef] [PubMed]
  34. Mundt, S.; Kreitlow, S.; Jansen, R. Fatty acids with antibacterial activity from the cyanobacterium oscillatoria redekei HUB 051. J. Appl. Phycol. 2003, 15, 263–267. [Google Scholar] [CrossRef]
  35. Li, B.; Wu, J.; Li, X. Quantitative determination of corosolic acid in rat plasma by LC-MS/MS-ESI: Application to a pharmacokinetic study. Pak. J. Pharm. Sci. 2014, 27, 511–516. [Google Scholar]
  36. Tan, Z.-R.; Chen, Y.; Zhou, G.; Cao, S.; Peng, X.-D.; Wang, Y.-C.; Peng, X.-J.; Zhang, W.; Zhou, H.-H. LC–MS–MS quantitative determination of ursolic acid in human plasma and its application to pharmacokinetic studies. Chromatographia 2010, 72, 1107–1113. [Google Scholar] [CrossRef]
  37. Karahisar, E.; Tugay, O.; Orhan, I.E.; Sezer Senol Deniz, F.; Vlad Luca, S.; Skalicka-Wozniak, K.; Sahin, M. Metabolite profiling by hyphenated liquid chromatographic mass spectrometric technique (HPLC-DAD-ESI-Q-TOF-MS/MS) and neurobiological potential of Haplophyllum sahinii and H. vulcanicum Extracts. Chem. Biodivers. 2019, 16, e1900333. [Google Scholar] [CrossRef] [PubMed]
  38. Tang, L.; Li, F.X.; Yang, S.X.; Qiu, Y.; Yuan, K. Chemical constituents of Hyptis rhomboidea and their antifungal activity. China J. Chin. Mater. Med. 2014, 39, 2284–2288. [Google Scholar]
  39. Kandaswami, C.; Lee, L.T.; Lee, P.P.; Hwang, J.J.; Ke, F.C.; Huang, Y.T.; Lee, M.T. The antitumor activities of flavonoids. In Vivo 2005, 19, 895–909. [Google Scholar]
  40. Sun, Q.; Liu, Q.; Zhou, X.; Wang, X.; Li, H.; Zhang, W.; Yuan, H.; Sun, C. Flavonoids regulate tumor-associated macrophages—From structure-activity relationship to clinical potential (review). Pharmacol. Res. 2022, 184, 106419. [Google Scholar] [CrossRef]
  41. Hill, C.U.F.K.; Saad, S.E.A.; Britton, R.G.; Gescher, A.J.; Sale, S.; Brown, K.; Howells, L.M. Inhibition of prostate cancer cell growth by 3′,4′,5′-trimethoxyflavonol (TMFol). Cancer Chemother. Pharm. 2015, 76, 179–185. [Google Scholar] [CrossRef]
  42. Zhang, X.A.; Zhang, S.; Yin, Q.; Zhang, J. Quercetin induces human colon cancer cells apoptosis by inhibiting the nuclear factor-kappa B Pathway. Pharmacogn. Mag. 2015, 11, 404–409. [Google Scholar] [CrossRef]
  43. Xiao, J.; Zhang, B.; Yin, S.; Xie, S.; Huang, K.; Wang, J.; Yang, W.; Liu, H.; Zhang, G.; Liu, X.; et al. Quercetin induces autophagy-associated death in HL-60 cells through CaMKKβ/AMPK/mTOR signal pathway. Acta Biochim. Biophys. Sin. (Shanghai) 2022, 54, 1244–1256. [Google Scholar] [PubMed]
  44. Tao, S.F.; He, H.F.; Chen, Q. Quercetin inhibits proliferation and invasion acts by up-regulating miR-146a in human breast cancer cells. Mol. Cell. Biochem. 2015, 402, 93–100. [Google Scholar] [CrossRef]
  45. Rauf, A.; Imran, M.; Khan, I.A.; Ur-Rehman, M.; Gilani, S.A.; Mehmood, Z.; Mubarak, M.S. Anticancer potential of quercetin: A comprehensive review. Phytother. Res. 2018, 32, 2109–2130. [Google Scholar] [CrossRef] [PubMed]
  46. Shahbaz, M.; Imran, M.; Alsagaby, S.A.; Naeem, H.; Al Abdulmonem, W.; Hussain, M.; Abdelgawad, M.A.; El-Ghorab, A.H.; Ghoneim, M.M.; El-Sherbiny, M.; et al. Anticancer, antioxidant, ameliorative and therapeutic properties of kaempferol. Int. J. Food Prop. 2023, 26, 1140–1166. [Google Scholar] [CrossRef]
  47. Everton Freitas de Morais, E.F.; de Oliveira, L.Q.R.; Farias Morais, H.G.d.; Souto Medeiros, M.R.d.; Freitas, R.d.A.; Rodini, C.O.; Coletta, R.D. The Anticancer Potential of Kaempferol: A Systematic Review Based on In Vitro Studies. Cancers 2024, 16, 585. [Google Scholar] [CrossRef]
  48. Riaz, A.; Rasul, A.; Hussain, G.; Zahoor, M.K.; Jabeen, F.; Subhani, Z.; Younis, T.; Ali, M.; Sarfraz, I.; Selamoglu, Z. Astragalin: A Bioactive Phytochemical with Potential Therapeutic Activities. Adv. Pharmacol. Sci. 2018, 2018, 9794625. [Google Scholar] [CrossRef]
  49. Pandey, P.; Ramniwas, S.; Verma, M.; Rautela, I.; Khan, F.; Shah, M.A. A comprehensive review uncovering the anticancerous potential of genkwanin (plant-derived compound) in several human carcinomas. Open Chem. 2024, 22, 20240003. [Google Scholar] [CrossRef]
  50. Fuster, M.G.; Carissimi, G.; Montalbán, M.G.; Víllora, G. Antitumor activity of rosmarinic acid-loaded silk fibroin nanoparticles on HeLa and MCF-7 cells. Polymers 2021, 13, 3169. [Google Scholar] [CrossRef]
  51. Zhang, C.; Niu, Y.; Wang, Z.; Xu, X.; Li, Y.; Ma, L.; Wang, J.; Yu, Y. Corosolic acid inhibits cancer progression by decreasing the level of CDK19-mediated O-GlcNAcylation in liver cancer cells. Cell Death Dis. 2021, 12, 889. [Google Scholar] [CrossRef]
  52. Saleh, A.; ElFayoumi, H.M.; Youns, M.; Barakat, W. Rutin and orlistat produce antitumor effects via antioxidant and apoptotic actions. Naunyn-Schmiedeberg’s Arch. Pharmacol. 2019, 392, 165–175. [Google Scholar] [CrossRef] [PubMed]
  53. Nile, A.; Nile, S.H.; Cespedes-Acuña, C.L.; Oh, J.-W. Spiraeoside extracted from red onion skin ameliorates apoptosis and exerts potent antitumor, antioxidant and enzyme inhibitory effects. Food Chem. Toxicol. 2021, 154, 112327. [Google Scholar] [CrossRef] [PubMed]
  54. Suhaimi, S.A.; Hong, S.L.; Abdul Malek, S.N. Rutamarin, an Active Constituent from Ruta angustifolia Pers., Induced Apoptotic Cell Death in the HT29 Colon Adenocarcinoma Cell Line. Pharmacogn. Mag. 2017, 13, S179–S188. [Google Scholar] [PubMed]
  55. Spanova, M.; Daum, G. Squalene–biochemistry, molecular biology, process biotechnology, and applications. Eur. J. Lipid Sci. Technol. 2011, 113, 1299–1320. [Google Scholar] [CrossRef]
  56. Li, K.; Yuan, D.; Yan, R.; Meng, L.; Zhang, Y.; Zhu, K. Stigmasterol exhibits potent antitumor effects in human gastric cancer cells mediated via inhibition of cell migration, cell cycle arrest, mitochondrial mediated apoptosis and inhibition of JAK/STAT signalling pathway. J. BUON 2018, 23, 1420–1425. [Google Scholar]
  57. Choi, J.-M.; Lee, E.-O.; Lee, H.-J.; Kim, K.H.; Ahn, K.s.; Shim, B.; Kim, N.-I.; Song, M.C.; Baek, N.-I.; Kim, S.-H. Identification of campesterol from Chrysanthemum coronarium L. and its antiangiogenic activities. Phytother. Res. 2007, 21, 954–959. [Google Scholar] [CrossRef] [PubMed]
  58. Zhang, Y.; Sun, X.; Nan, N.; Cao, K.X.; Ma, C.; Yang, G.W.; Yu, M.W.; Yang, L.; Li, J.P.; Wang, X.M.; et al. Elemene inhibits the migration and invasion of 4T1 murine breast cancer cells via heparanase. Mol. Med. Rep. 2017, 16, 794–800. [Google Scholar] [CrossRef]
  59. La Torre, C.; Loizzo, M.R.; Frattaruolo, L.; Plastina, P.; Grisolia, A.; Armentano, B.; Cappello, M.S.; Cappello, A.R.; Tundis, R. Chemical profile and bioactivity of Rubus idaeus L. fruits grown in conventional and aeroponic systems. Plants 2024, 13, 1115. [Google Scholar] [CrossRef]
  60. O’Toole, S.A.; Sheppard, B.L.; McGuinness, E.P.J.; Gleeson, N.C.; Yoneda, M.; Bonnar, J. The MTS assay as an indicator of chemosensitivity/resistance in malignant gynaecological tumours. Cancer Detect. Prev. 2003, 27, 47–54. [Google Scholar] [CrossRef]
  61. Li, P.; Bai, G.; He, J.; Liu, B.; Long, J.; Morcol, T.; Peng, W.; Quan, F.; Luan, X.; Wang, Z.; et al. Chromosome-level genome assembly of Amomum tsao-ko provides isights into the biosynthesis of flavor compounds. Hortic. Res. 2022, 9, uhac211. [Google Scholar] [CrossRef]
Molecules 29 04216 g001
Figure 1. Exterior view of Hyptis rhomboidea Mart. et Gal.
Figure 1. Exterior view of Hyptis rhomboidea Mart. et Gal.
Molecules 29 04216 g001
Molecules 29 04216 g002
Figure 2. Cytotoxic activity of the 95% ethanol extract (HR-95) and the 50% ethanol extract (HR-50) of H. rhomboidea on five human cancer cell lines. The five human cancer cell lines include leukemia cells (HL-60), hepatoma cells (A549), lung cancer cells (SMMC-7721), breast cancer cells (MDA-MB-231), colon cancer cells (SW480), and human normal lung epithelial cells (BEAS-2B). The extract concentration was 100 μg/mL, and the value means the cell inhibition rate ± SD of cancer cells (n = 3).
Figure 2. Cytotoxic activity of the 95% ethanol extract (HR-95) and the 50% ethanol extract (HR-50) of H. rhomboidea on five human cancer cell lines. The five human cancer cell lines include leukemia cells (HL-60), hepatoma cells (A549), lung cancer cells (SMMC-7721), breast cancer cells (MDA-MB-231), colon cancer cells (SW480), and human normal lung epithelial cells (BEAS-2B). The extract concentration was 100 μg/mL, and the value means the cell inhibition rate ± SD of cancer cells (n = 3).
Molecules 29 04216 g002
Molecules 29 04216 g003
Figure 3. The cell viability curves of five human cancer cell lines (HL-60, A549, SMMC-7721, MDA-MB-231, and SW480) and normal human lung epithelial cells (BEAS-2B) treated with different concentrations of HR-95, cisplatin, and Taxol. HR-95: 95% ethanol extract of H. rhomboidea. The concentration of HR-95 for BEAS-2B was only 100 μg/mL. The x-axis represents the compound concentrations, with a maximum concentration of 100 μg/mL for HR-95, 12.00 μg/mL (40 μM) for cisplatin, and 4.27 μg/mL (5 μM) for Taxol. The y-axis represents the mean ± standard deviation of cell viability (n = 3).
Figure 3. The cell viability curves of five human cancer cell lines (HL-60, A549, SMMC-7721, MDA-MB-231, and SW480) and normal human lung epithelial cells (BEAS-2B) treated with different concentrations of HR-95, cisplatin, and Taxol. HR-95: 95% ethanol extract of H. rhomboidea. The concentration of HR-95 for BEAS-2B was only 100 μg/mL. The x-axis represents the compound concentrations, with a maximum concentration of 100 μg/mL for HR-95, 12.00 μg/mL (40 μM) for cisplatin, and 4.27 μg/mL (5 μM) for Taxol. The y-axis represents the mean ± standard deviation of cell viability (n = 3).
Molecules 29 04216 g003
Molecules 29 04216 g004
Figure 4. Base peak chromatograms of the 95% ethanol extract of H. rhomboidea (HR-95). (a) Base peak chromatograms of the positive ion mode. (b) Base peak chromatograms of the negative ion mode. Compound peaks are ranked by number.
Figure 4. Base peak chromatograms of the 95% ethanol extract of H. rhomboidea (HR-95). (a) Base peak chromatograms of the positive ion mode. (b) Base peak chromatograms of the negative ion mode. Compound peaks are ranked by number.
Molecules 29 04216 g004
Molecules 29 04216 g005
Figure 5. Total ion chromatogram of the 95% ethanol extract of H. rhomboidea (HR-95). Compound peaks were ranked by number.
Figure 5. Total ion chromatogram of the 95% ethanol extract of H. rhomboidea (HR-95). Compound peaks were ranked by number.
Molecules 29 04216 g005
Molecules 29 04216 g006
Figure 6. Relative content of identified volatile compounds. (a) Relative content of compounds classified by functional groups. (b) Relative content of different terpenoid types.
Figure 6. Relative content of identified volatile compounds. (a) Relative content of compounds classified by functional groups. (b) Relative content of different terpenoid types.
Molecules 29 04216 g006
Table 1. Inhibitory rate (%) of two H. rhomboidea ethanol extracts on five types of human cancer cells.
Table 1. Inhibitory rate (%) of two H. rhomboidea ethanol extracts on five types of human cancer cells.
GroupsHL-60A549SMMC-7721MDA-MB-231SW480BEAS-2B
HR-9596.10 ± 0.1378.24 ± 0.9079.43 ± 1.3590.54 ± 1.0185.64 ± 0.2614.20 ± 1.43
HR-50−41.52 ± 1.033.64 ± 1.6420.40 ± 0.5712.35 ± 2.9216.24 ± 1.111.27 ± 0.68
HR-95 means the 95% ethanol extract of H. rhomboidea; HR-50 means the 50% ethanol extract of H. rhomboidea. The extract concentration was 100 μg/mL. BEAS-2B is human normal lung epithelial cells (non-cancer cell line), and the values are expressed as mean ± SD of cell inhibition rate (n = 3).
Table 2. The IC50 value (μg/mL) of H. rhomboidea crude extract on five human cancer cell lines.
Table 2. The IC50 value (μg/mL) of H. rhomboidea crude extract on five human cancer cell lines.
GroupsHL-60A549SMMC-7721MDA-MB-231SW480BEAS-2B
HR-9536.44 ± 1.8240.02 ± 0.5826.20 ± 0.7722.95 ± 1.5915.81 ± 0.63>100
Cisplatin4.25 ± 0.225.40 ± 0.125.05 ± 0.205.07 ± 0.397.52 ± 0.3823.44 ± 1.14
Taxol<0.007<0.0070.466 ± 0.25<0.007<0.0072.44 ± 0.42
HR-95: 95% ethanol extract of H. rhomboidea. Cisplatin and Taxol were used as positive controls. The values are expressed as mean ± SD of IC50 (n = 3).
Table 4. Essential compounds in the 95% ethanol extracts of Hyptis rhomboidea extracted using GC-MS.
Table 4. Essential compounds in the 95% ethanol extracts of Hyptis rhomboidea extracted using GC-MS.
Peak No.RT (min)CompoundMolecular
Formula		Library No.MatchRetention IndexRelative Content
(%)
Average RILib.RI
17.495m-CymeneC10H14535-77-3801102610230.16%
28.155γ-TerpineneC10H1699-85-4838106010600.13%
38.940LinaloolC10H18O78-70-6848110010990.28%
410.455endo-BorneolC10H18O507-70-0902117811670.21%
510.915EstragoleC10H12O140-67-0890120111960.22%
614.175α-YlangeneC15H2414912-44-8880137813720.14%
714.290(-)-alpha-CopaeneC15H243856-25-5895138413760.62%
815.090CaryophylleneC15H2487-44-5845140414190.18%
915.710HumuleneC15H246753-98-6839146714540.21%
1015.985γ-MuuroleneC15H2430021-74-0927148314770.98%
1116.060α-MuuroleneC15H2431983-22-9919148814990.14%
1216.275β-EudesmeneC15H2417066-67-0836150014860.24%
1316.4052,4-Di-tert-butylphenolC14H22O96-76-4870150915191.56%
1416.630γ-CadineneC15H2439029-41-9939152315130.79%
1516.690δ-CadineneC15H24483-76-1855152615240.49%
1616.760CalameneneC15H22483-77-2870153115230.38%
1717.010α-CadineneC15H2424406-05-1870154715380.20%
1817.820Caryophyllene oxideC15H24O1139-30-6800159715810.32%
1918.435Muurola-4,10(14)-dien-1β-olC15H24O257293-90-6844163816350.44%
2018.68510-epi-α-CadinolC15H26O1474790870165415800.06%
2121.305NeophytadieneC20H38504-96-1920183618370.64%
2221.385Hexahydrofarnesyl acetoneC18H36O502-69-2904184218441.23%
2321.675Diisobutyl phthalateC16H22O484-69-5877186318700.15%
2421.895NeophytadieneC20H38504-96-1910187917740.26%
2522.350Farnesyl palmitateC31H56O2157501-12-7810191332250.18%
2622.940Dibutyl phthalateC16H22O484-74-2825195919650.09%
2722.980n-Hexadecanoic acidC16H32O257-10-3851196219680.72%
2823.360Hexadecanoic acid, ethyl esterC18H36O2628-97-7903199119930.21%
2924.850PhytolC20H40O150-86-7892211121140.67%
3026.0352-Hexadecen-1-ol, 3,7,11,15-
Tetramethyl-, acetate		C22H42O276337-16-1911221222321.50%
3126.395Tributyl acetylcitrateC20H34O877-90-7801224322500.14%
3227.6254,8,12,16-Tetramethylheptadecan
-4-olide		C21H40O296168-15-9804235423640.28%
3328.645Unknown-----19.86%
3429.530Unknown-----14.39%
3531.370HeptacosaneC27H56593-49-7857269927001.14%
3632.960SqualeneC30H50111-02-4925281628324.27%
3734.290NonacosaneC29H60630-03-5830290729000.94%
3838.550DotriacontaneC32H66544-85-4820319732000.47%
3939.385Vitamin EC29H50O259-02-9940325431490.73%
4042.480CampesterolC28H48O474-62-4800346531311.00%
4143.320StigmasterolC29H48O83-48-7840352231702.85%
RT: retention time. RI: retention index. Library No. includes the CAS ID and NIST ID of compounds. Relative content is calculated by peak area/total peak area of compounds.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Zhang, J.; Gao, W.; Jahan, I.; Zhai, R.; Yao, K.; Yan, J.; Li, P. The Cytotoxic Activity and Metabolic Profiling of Hyptis rhomboidea Mart. et Gal. Molecules 2024, 29, 4216. https://doi.org/10.3390/molecules29174216

AMA Style

Zhang J, Gao W, Jahan I, Zhai R, Yao K, Yan J, Li P. The Cytotoxic Activity and Metabolic Profiling of Hyptis rhomboidea Mart. et Gal. Molecules. 2024; 29(17):4216. https://doi.org/10.3390/molecules29174216

Chicago/Turabian Style

Zhang, Jian, Wenjie Gao, Israt Jahan, Run Zhai, Kaiwei Yao, Jian Yan, and Ping Li. 2024. "The Cytotoxic Activity and Metabolic Profiling of Hyptis rhomboidea Mart. et Gal" Molecules 29, no. 17: 4216. https://doi.org/10.3390/molecules29174216

Article Metrics

Back to TopTop